nasal spray depression - Search News

FDA-Approved Nasal Spray For Depression Is 1st Of Its Kind

Popular Science · 2d

FDA approves first-of-its-kind nasal spray for severe depression

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD, and similar psychiatric conditions.

FDA OKs Esketamine Nasal Spray Monotherapy for Resistant Depression

The expanded indication allows esketamine nasal spray to be used as a standalone treatment in adults with MDD who have not responded to at least two oral antidepressants.

Hosted on MSN · 1d

FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as stand-alone treatment

The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult population.

10hon MSN

Can a nasal spray cure loneliness? Effects of hormone spritz lasted for months in study

Researchers delivered a dose of the “love hormone” oxytocin via a nasal spray to participants and found that it decreased ...

ScienceAlert on MSN1d

FDA-Approved Nasal Spray For Depression Is First Of Its Kind

A ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results